Article
Identification of age-associated transcriptomic changes linked to immunotherapy response in primary melanoma
2022-01-25
Abstract excerpt
Melanoma is a lethal form of skin cancers that develops due to constitutive activation of MAPK signaling pathway driven by BRAF and NRAS mutations. Immunotherapeutic agents such as anti-PD-1 (pembrolizumab and nivolumab) and anti-CTLA-4 (ipilimumab) have revolutionized melanoma treatment, however drug resistance is rapidly acquired. Several studies reported the increase in melanoma rates in older patients. Thus, t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4383ff56-1b76-5c6a-af0d-5b692111f456
- DOI
- 10.1101/2022.01.23.22269554
